HBsAg seroclearance and reduction in late recurrence of HBV-related HCC: Causality or co-existence?

J Hepatol. 2022 Nov;77(5):1468-1469. doi: 10.1016/j.jhep.2022.06.009. Epub 2022 Jun 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / epidemiology
  • Carcinoma, Hepatocellular* / etiology
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Hepatitis B virus / genetics
  • Humans
  • Liver Neoplasms* / complications
  • Liver Neoplasms* / etiology

Substances

  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens